查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球输尿管支架市场
市场调查报告书
商品编码
1143394

2022-2029 年全球输尿管支架市场

Global Ureteral Stents Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

预计输尿管支架市场在预测期间（2022-2029 年）将以 5.8% 的复合年增长率增长。

输尿管支架是细而柔韧的管子，可通过因各种疾病而阻塞的输尿管恢復尿液流动。市场上用于支架病例管理和患者安全的创新界面平台对患者和医生都有好处。流行病学数据显示，肾结石病患病率不断上升，进一步增加了对输尿管支架的需求。

市场动态

全球输尿管支架市场受到泌尿系统疾病发病率上升、肾功能损害老年人口增加和肾移植增加的推动。

肾移植数量的增加和人口老龄化正在推动全球市场的增长。

预计肾移植的增加将推动市场。例如，根据全球捐赠和移植观察站的数据，2020 年捐赠了超过 80,926 个肾臟，2021 年捐赠了大约 98,349 个。个人首次接受肾移植的中位等待时间约为 3.6 年，具体取决于适用性、健康状况和器官可用性。根据与 NHS England 合作的 NHS Blood and Transplant 发布的一份报告，截至 2022 年 2 月 24 日，共有 4,658 个有效的候补名单，其中 98 人是儿童。这个数字预计会增长。因此，肾移植的增加和对泌尿系统功能障碍的日益关注导致对提高术后便利性的输尿管支架的需求激增。

此外，预计不断增长的老年人口将推动全球输尿管支架市场。例如，根据世界卫生组织的数据，65 岁的人口将从 2020 年估计的 10 亿增加到 2030 年的 14 亿，到 2050 年世界老年人口将翻一番（21 亿）。到 2050 年， 80岁及以上人口将达到4.26亿，其中大部分增长在发展中国家。老年病学的增加也反映在肾结石等医疗问题的增加上。老年科医生和肾臟科医生在这些患者的护理中发挥着重要作用，需要协调的多学科护理。

支架移除后并发症的高风险阻碍了全球市场的增长。

然而，支架移除后并发症的高风险可能会抑制市场。使用尿道支架可能会发生与脱位、阻塞和感染有关的几种并发症。人们还可能感到尿急、排尿频率增加、肾痛和尿液混浊。这些因素将刺激医学研发部门开发更好的输尿管支架替代品，并可能在预测期内影响市场增长。

行业分析

《全球输尿管支架市场报告》根据波特五力、创新、新产品发布和定价等各种行业因素对市场进行了深入分析。

细分分析

预计多环支架细分市场将在预测期内（2022-2029 年）主导全球市场。

由于与泌尿系统疾病患病率上升、老年人口增加和并发症减少相关的多环支架段的技术进步，多环支架段将在预测期内（2022-2029 年）增长。预计将在率最高。此外，这些支架的高采用率以及主要供应商采用各种营销策略正在推动其增长。多环输尿管支架由训练有素的医生设计，用于暂时促进尿液从肾臟排入膀胱。多环输尿管支架的市场领导者是 MEDpro Medical，它在单端多环双 J 支架和双端多环双 J 支架方面取得了成功。此外，Surgimedik 的胆道双 J 支架（均为 endo-multi-loop）是独一无二的。

区域分析

估计北美将主导全球输尿管支架市场。

北美将在 2021 年主导全球输尿管支架市场，慢性肾脏病发病率上升，肾结石等泌尿系统疾病，老年人口不断增加，久坐不动的生活方式增加，肾移植预测期（2022-2029 年）由于 .例如，根据 LifeSource 的统计，截至 2022 年 7 月 20 日，超过 89,898 名美国公民正在等待挽救生命的肾臟移植手术。此外，根据 Kidney.org 的数据，每年有超过 500,000 人因一个问题而去急诊室。此外，总部位于美国的主要公司采取了各种策略，如产品发布、公司扩张和合併，以推动北美市场的增长。例如，大学医院克利夫兰医学中心正在临床试验中开发 RELIEF(TM) 输尿管支架，以评估逆行尿流和远端螺旋膀胱位置。这是一种一次性输尿管支架装置，在其传统功能的基础上进行了新的设计改进，可让尿液从肾臟进入膀胱，最大限度地减少尿液反流和防止膀胱刺激，还具有减轻症状和改善患者护理的好处。该考试的完成日期为 2022 年 12 月。

竞争格局

在全球输尿管支架市场运营的主要公司有波士顿科学公司、B. Braun Holding GmbH & Co.KG、库克集团公司、康乐保公司、C. R. Bard, Inc.、Medline Industries, Inc.、Allium Medical Solutions Ltd、Penn Medical A/S、Teleflex Incorporated 和 Olympus Corporation。主要参与者采取了各种策略，如产品发布、併购、合作伙伴和联盟，为全球输尿管支架市场的增长做出贡献。例如，2022 年 5 月 2 日，Cook Medical 的 Winston-Salem 製造工厂获得了 ISO 14001 认证。同样在 2021 年 5 月 28 日，奥林巴斯公司收购了以色列医疗器械公司 Meditate。

波士顿科学公司

概述

波士顿科学公司专注于介入放射学、介入心脏病学、外周介入、神经调节、神经血管介入、电生理学、心臟外科、血管外科、内窥镜检查，是一家全球领先的生物医学和生物技术工程公司，从事製造用于医疗器械的医疗器械肿瘤科、泌尿科、妇科等介入医学专科。波士顿科学公司成立于 1979 年，总部位于美国马萨诸塞州马尔堡。

产品组合

Boston Scientific 的输尿管支架产品组合如下。

Contour 输尿管支架、Contour Injection 输尿管支架组、Percuflex 泌尿分流支架组、Percuflex 输尿管支架、Polaris Loop 输尿管支架。

Polaris Ultra 输尿管支架、Retromax Plus 内窥镜支架、Stretch VL Flexima 输尿管支架组、Tria 输尿管支架等。

全球输尿管支架市场报告将提供对 40 多个 市场数据表、超过 45 个数字和 200 页（大约）的访问。

内容

第1章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 肾移植数量增加
      • 老年人口增加
    • 约束因素
      • 支架取出后的并发症
    • 商机
    • 影响分析

第5章行业分析

  • 波特五力分析
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 多循环
  • 开口支架
  • 闭合端支架
  • 双尾纤支架

第 8 章按材料分类

  • 金属支架
  • 硅胶支架
  • 混合支架
  • 聚氨酯支架
  • 其他

第 9 章按应用程序

  • 肾结石
  • 肾移植
  • 肿瘤
  • 尿失禁
  • 其他

第 10 章，最终用户

  • 医院和诊所
  • 门诊手术中心
  • 其他

第 11 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 12 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 产品基准

第 13 章公司简介

  • 波士顿科学公司
    • 公司简介
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • B. Braun Holding GmbH & Co. KG
  • Cook Group Incorporated
  • Coloplast Ltd.
  • C. R. Bard, Inc.
  • Medline Industries, Inc
  • Allium Medical Solutions Ltd
  • Penn Medical A/S
  • Teleflex Incorporated
  • Olympus Corporation

第14章 DataM

简介目录
Product Code: DMMD1957

Market Overview

Ureteral Stents Market is expected to grow at a CAGR of 5.8% during the forecasting period (2022-2029).

Ureteral stents are thin, flexible tubes that restore urine flow through blocked ureters due to various disorders. Innovative interface platforms available in the market for stent case management and patient safety are useful for both patients and physicians. Epidemiological data revealed that the prevalence of kidney stone disease is increasing, which further increases the demand for ureteral stents.

Market Dynamics

The global ureteral stents market is driven by the rising incidence of urological diseases, the rising geriatric population with kidney disorders, and an increasing number of kidney transplants.

The rising number of kidney transplants and the growing geriatric population fuel the growth of the global market.

The increasing number of kidney transplants is expected to drive the market. For instance, according to the Global Observatory on Donation and Transplantation, in 2020, there were over 80,926 kidneys donated, and in 2021 around 98,349 kidneys were donated. The median wait time for an individual's first kidney transplant is around 3.6 years and varies depending on compatibility, health, and availability of organs. According to the report published by NHS Blood and Transplant, which works in collaboration with NHS England, the active waiting list as of 24 February 2022 has 4,658 patients waiting for a kidney, including 98 children. This number is expected to rise. Thus, the growing number of renal transplants and raising concerns related to urological dysfunction have surged the demand for ureteral stents for post-operative convenience.

Furthermore, the growing geriatric population is expected to drive the global ureteral stents market. For instance, as per World Health Organization, the number of people aged 65 is expected to rise from an estimated 1 billion in 2020 to 1.4 billion in 2030; the world's geriatric population will double (2.1 billion) by 2050 and between 2020 and 2050, the persons aged 80 years or older will reach to 426 million, with most of the increase in developing countries. This increase in geriatrics will be reflected by the rise in medical problems such as kidney stones. It requires coordinated care by multiple specialties, with geriatricians and nephrologists playing a vital role in treating these patients.

The high risk of complications post-stent removal will hamper the global market growth.

However, the high risk of complications after the removal of stents is likely to restrain the market. Some complications related to dislocation, blockage, and infection may arise because of the usage of a urinary stent. The patient may also feel an increased urgency or frequency of urination, kidney pain, and blood in the urine. These factors surge the medical research and development departments to develop a better alternative to ureteral stents and can affect the market growth in the forecast period.

Industry Analysis

The global ureteral stents market report will provide an in-depth analysis of the market based on various industry factors such as porter`s five forces, innovations, new product launches, pricing, Etc.

Segment Analysis

The multiloop stents segment is predicted to dominate the global market during the forecast period (2022-2029).

The multiloop stents segment is expected to grow at the highest rate during the forecast period (2022-2029) because of the rise in the prevalence of urological disorders, the growing geriatric population, and technological advancements in the multiloop stents segment associated with reduced complications. Also, the high adoption of these stents and the adoption of various marketing strategies by critical vendors foster its growth. The Multiloop Ureteral Stent is intended to temporarily facilitate urine drainage from kidney to bladder by a trained physician. One of the market leaders on the multiloop ureteral stents front is MEDpro Medical, with their successful Double J Stent one-end multiple loops and Double J Stent, both end multiple loop products. Also, the Biliary double J stent, both end multiple loops of Surgimedik, is one of a kind.

Geographical Analysis

North America is estimated to command the global ureteral stents market.

North America dominated the global ureteral stents market in 2021 and is estimated to hold a significant market size over the forecast period (2022-2029) owing to the rising incidences of urological diseases like chronic kidney diseases, kidney stones, Etc., rising geriatric population base, increasing sedentary lifestyles, growing kidney transplantations. For instance, according to LifeSource statistics, as of July 20, 2022, over 89,898 United States citizens are waiting for a lifesaving kidney transplant. Furthermore, as per Kidney.org, more than half a million people yearly go to emergency rooms stones one problem. In addition, the US-based major players are adopting various strategies, including product launches, company expansion, mergers, and others, fueling the market's growth in North America. For instance, University Hospitals Cleveland Medical Center is developing the RELIEF™ Ureteral Stent in clinical trials to assess Retrograde Urinary Reflux and Distal Coil Bladder Position. It is a single-use, disposable ureteral stent device which provides the traditional function of allowing the passage of urine from the kidney to the bladder with new design enhancements, also with the benefits of minimizing urinary reflux and decreasing irritative bladder symptoms to improve patient care. According to the reports, the estimated study completion date is December 2022.

Competitive Landscape

The major players operating in the global ureteral stents market are Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Cook Group Incorporated, Coloplast Ltd., C. R. Bard, Inc., Medline Industries, Inc., Allium Medical Solutions Ltd, Penn Medical A/S, Teleflex Incorporated, and Olympus Corporation. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the ureteral stents market globally. For instance, on 02 May 2022, Cook Medical's Winston-Salem manufacturing facility secured ISO 14001 Certification. Also, on May 28, 2021, Olympus Corporation acquired Medi-Tate, an Israeli Medical Device Company.

Boston Scientific Corporation

Overview:

Boston Scientific Corporation is a leading biomedical/biotechnology engineering Company involved in the global production of medical devices that are used in interventional medical specialties, such as interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. Boston Scientific was founded in 1979 and is headquartered in Marlborough, Massachusetts, U.S.

Product Portfolio:

Boston Scientific Corporation's product portfolio for ureteral stents has

Contour Ureteral Stents, Contour Injection Ureteral Stent Set, Percuflex Urinary Diversion Stent Set, Percuflex Ureteral Stent, Polaris Loop Ureteral Stent,

Polaris Ultra Ureteral Stent, Retromax Plus Endopyelotomy Stent, Stretch VL Flexima Ureteral Stent Set, Tria Ureteral Stents, Etc.

The global ureteral stents market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Number of Kidney Transplants
      • 4.1.1.2. The Growing Geriatric Population
    • 4.1.2. Restraints
      • 4.1.2.1. Post Stent Removal Complications
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. Multiloop
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Open-end stents
  • 7.4. Closed-end stents
  • 7.5. Double pigtail stents

8. By Material

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Segment
    • 8.1.2. Market Attractiveness Index, By Material Segment
  • 8.2. Metal Stents
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Silicone Stents
  • 8.4. Hybrid Stents
  • 8.5. Polyurethane Stents
  • 8.6. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 9.1.2. Market Attractiveness Index, By Application Segment
  • 9.2. Kidney Stones
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Kidney Transplantation
  • 9.4. Tumors
  • 9.5. Urinary Incontinence
  • 9.6. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 10.1.2. Market Attractiveness Index, By End User Segment
  • 10.2. Hospitals and Clinics
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Ambulatory Surgical Centers
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Company Profiles

  • 13.1. Boston Scientific Corporation
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. B. Braun Holding GmbH & Co. KG
  • 13.3. Cook Group Incorporated
  • 13.4. Coloplast Ltd.
  • 13.5. C. R. Bard, Inc.
  • 13.6. Medline Industries, Inc
  • 13.7. Allium Medical Solutions Ltd
  • 13.8. Penn Medical A/S
  • 13.9. Teleflex Incorporated
  • 13.10. Olympus Corporation

LIST NOT EXHAUSTIVE

14. DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us